Verastem (VSTM) Other Accumulated Expenses (2011 - 2026)
Verastem (VSTM) reported Other Accumulated Expenses of $3.9 million for Q2 2026, up 119.3% from $1.78 million a year earlier and up 24.0% from the prior quarter.
Powered by 
Analysis
Verastem (VSTM) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Verastem posted Other Accumulated Expenses of $3.02 million, up 121.9% from FY2024.
- Other Accumulated Expenses has increased for three consecutive years, though with a five-year compound annual growth rate of -10.2% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $1.36 million in FY2024 (+26.2%), $1.08 million in FY2023 (+8.1%), $996,000 in FY2022 (-89.3%) and $9.31 million in FY2021 (+79.9%).
- The Q2 2026 figure ranks as the highest quarterly Other Accumulated Expenses since Q3 2023.
- Year over year, Other Accumulated Expenses has now increased in each of the last seven quarters, with growth averaging 49.1% over the last eight quarters.
- The high point for year-over-year Other Accumulated Expenses in five years was Q3 2021 (growth of 705.2%); the low point was Q4 2022 (a decline of 89.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.14 million (Q1 2026), $3.02 million (Q4 2025) and $2.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Verastem | 824.71 Mn | 172.86 Mn | 20.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.00 Mn |
| Jun 30, 2026 | 3.90 Mn |
| Mar 31, 2026 | 3.14 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 1.78 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 9.05 Mn |
| Jun 30, 2023 | 7.70 Mn |
| Mar 31, 2023 | 8.95 Mn |
| Dec 31, 2022 | 996,000.00 |
| Sep 30, 2022 | 8.16 Mn |
| Jun 30, 2022 | 12.62 Mn |
| Mar 31, 2022 | 9.37 Mn |
| Dec 31, 2021 | 9.31 Mn |
API Access
Verastem Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VSTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "VSTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VSTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();